Firefly to offer NeuroSigma’s non-drug ADHD device to clinicians
The collaboration pairs Firefly's AI-powered brain-assessment platform with NeuroSigma's FDA-cleared, non-medication device for children with ADHD.
Treatments
FDA approves mini version of RECELL GO for smaller wounds
Signati submits De Novo application to FDA after completing trial
Inquis Medical secures $40m funding to advance thrombectomy system
Fish-skin grafts outperform current treatments in diabetic foot ulcers
eGenesis scoops $191m for genetically modified pig kidney transplant trial
Spectral AI hits enrollment goal at burn centres for AI-powered assessment tech
AA Medical acquires Surgical Product Solutions
